(PR NEWSWIRE) Preferred Capital Markets, Inc. Issues Industry Report on Re
Preferred Capital Markets, Inc. Issues Industry Report on Refractive Vision
Correction
SAN FRANCISCO, Sept. 15 /PRNewswire/ -- The following is being issued by
Preferred Capital Markets, Inc., a member of the National Association of
Securities Dealers, CRD number 10993:
Preferred Capital Markets, Inc., a brokerage firm servicing both
institutional and individual investors with a focus on technology,
telecommunications and medical technology publishes 102 page industry report
"Refractive Vision Correction: Profitability in Sight with a Keen Eye on the
Market".
Kate Sharadin, Senior Analyst, and Jason Mills (Associate Analyst) have
published a comprehensive research report addressing the refractive vision
technology sector including research reports on:
LaserSight, Inc. (Nasdaq: LASE, Strong Buy); LaserSight, Inc. designs and
manufactures laser systems used for refractive vision correction.
Additionally, The Company offers a line of durable and single use
microkeratomes and disposable keratome blades that are used in each LASIK
procedure.
Staar Surgical Company (Nasdaq: STAA, Strong Buy); Staar Surgical Company
is a leading developer, manufacturer, and distributor of ophthalmic products
for the treatment of refractive, cataract, and glaucoma conditions.
Summit Technology, Inc. (Nasdaq: BEAM, Strong Buy); Summit Technology, Inc.
develops, manufacturers, and markets excimer laser systems to correct common
vision disorders such as nearsightedness, farsightedness, and astigmatism.
The Company also manufacturers and markets a line of microkeratome products,
including blades and durable keratomes, used to perform the LASIK surgery.
VISX, Inc. (Nasdaq: VISX, Buy); VISX, Incorporated is the leading
competitor in the US refractive (laser) vision correction market. We estimate
the Company has approximately 75% of the US market share in terms of procedure
volumes. The FDA approved the Company's laser in 1996, which currently has
the broadest range of approved indications for myopia, hyperopia and
astigmatism.
Preferred Capital Markets, Inc. provides proprietary research and trade
execution services on an agency and principal basis for the securities and
options markets. Clients include institutional investors, money managers,
floor traders, and high net worth individuals. Founded in 1982, Preferred
Capital Markets is headquartered in San Francisco with offices in New York,
Boston, Chicago and Philadelphia.
The information contained herein is not and does not purport to be a
complete analysis of every material fact respecting any company, industry, or
security. Preferred Capital Markets, Inc. and its affiliates make no
representation as to whether any of the companies mentioned herein are in
compliance with the informational reporting requirements of the Securities
Exchange Act of 1934. The firm makes a market in the aforementioned security.
Any statements nonfactual in nature herein constitute only current opinions or
estimates, represent only the current judgment of the author(s), and are
subject to change without notice. Preferred Capital Markets, Inc. (or one of
its affiliates) or their partners, officers, directors, analysts, employees or
customers may have an interest in the securities mentioned herein and may make
purchases or sales as principal or agent of these securities, or their
derivatives, while this report is in circulation. The information and
opinions expressed herein do not constitute an offer or solicitation with
respect to the purchase or sale of any security. Transactions in securities
mentioned herein may be effected only in those states where such securities
are qualified for sale.
SOURCE Preferred Capital Markets, Inc.
-0- 09/15/1999
/CONTACT: Hillari Allen of Preferred Capital Markets, Inc., 415-733-3049/
(LASE STAA BEAM VISX)
CO: Preferred Capital Markets, Inc.; LaserSight, Inc.; Staar Surgical
Company; Summit Technology, Inc.; VISX, Incorporated
ST: California
IN: FIN MTC
SU: RTG
*** end of s |
